Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors
Background: Conventional radiation therapy (RT) has produced unprecedented cure rates in patients with Hodgkin's lymphoma (HL) but exposed large volumes of nontargeted tissue to radiation (integral dose). Objective: Our goal was to report the effects of integral radiation dose on health outcome...
Main Authors: | Adam L. Holtzman, MD, John M. Stahl, MD, Simeng Zhu, MD, Christopher G. Morris, MS, Bradford S. Hoppe, MD, MPH, Jessica E. Kirwan, MA, Nancy P. Mendenhall, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109419300958 |
Similar Items
-
Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma
by: Nick Figura, MD, et al.
Published: (2017-04-01) -
Radiation Therapy for Advanced-Stage Hodgkin Lymphoma
by: Natalie A. Lockney, MD, et al.
Published: (2020-09-01) -
Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer
by: Lidia Guzhva, BS, et al.
Published: (2019-07-01) -
Self-Reported Sexual Function in Sexually Active Male Hodgkin Lymphoma Survivors
by: Corien M. Eeltink, RN, et al.
Published: (2020-09-01) -
Hepatic Hodgkin lymphoma with delayed enhancement on CT and MRI
by: Yukie Higuma, MD, et al.
Published: (2017-03-01)